Search Results - "Zahálková, J."

Determination of total antioxidant capacity in plasma by cyclic voltammetry. Two case reports by Psotová, J, Zahálková, J, Hrbác, J, Simánek, V, Bartek, J

“…The cyclic voltammetry (CV) was used for the measurement of the plasma total antioxidant capacity from two types of patients. The first one consisted of 29…”
Get full text

Histomorphometric diagnostics of renal osteopathy in chronic dialysis patients at high risk of cardiovascular disease by Žamboch, K., Krejčí, K., Škarda, J., Tichý, M., Überall, I., Skýpalová, P., Langová, K., Stejskal, D., Švesták, M., Zahálková, J., Ščudla, V., Zadražil, J.

“…Summary Chronic kidney disease–mineral and bone disorder (CKD–MBD) ranks among clinically and pathogenetically significant complications in patients with CKD…”
Get full text

Single photon bone densitometry in hemodialysis patients by Jaros, A, Zadrazil, J, Konecný, K, Kosatíková, Z, Zahálková, J, Vrublovský, P, Krejcí, K

“…Renal osteodystrophy is a common finding in patients with renal insufficiency. The maximum of its intensity is found in hemodialysis patients. Bone…”
Get more information

Anemia in chronic renal insufficiency and chronic failure by Zahálková, J

“…Complicated metabolic changes in chronic renal insufficiency interfere with the formation and survival of erythrocytes at many levels. Anaemia which thus…”
Get more information

An effect of continuous and intermittent renal replacement therapy on antibiotic treatment in critically ill patients with sepsis - a practice-based perspective of vancomycin and gentamycin therapies by Petejová, N, Martínek, A, Zahálková, J, Duricová, J, Plášek, J, Valkovský, I, Grundmann, M, Kacířová, I

“…Sepsis and septic shock are common cause of hospitalisation in intensive care unit. Acute kidney injury is an accompanying manifestation of sepsis/septic shock…”
Get more information

Clinicopathological aspects of Richter's syndrome by Krc, I, Macák, J, Krcová, V, Zahálková, J

“…Richter's syndrome represents an acute transformation of chronic lymphocytic leukaemia or other type of low-grade malignant non-Hodgkin lymphoma to highly…”
Get more information

Pharmacokinetics of gentamicin and vancomycin during continuous venovenous hemofiltration in critically ill septic patients with acute kidney injury by Petejova, N, Duricova, J, Martinek, A, Zahalkova, J

Get full text

4.P.223 Impaired triglyceride tolerance as a further risk factor for atherosclerosis in dialysis patients by Zahálková, J., Vaverková, H., Novotný, D.

Get full text

Dyslipoproteinemia and chronic kidney failure by Zahálková, J, Vaverková, H, Kristof, V

“…Lipoprotein abnormalities are a regular part of metabolic changes associated with chronic renal failure. The character of dyslipoproteinaemia changes with the…”
Get more information

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) leading to the diagnosis of Wilson's disease by Szotkowski, T, Frysák, Z, Papajík, T, Dusková, M, Zahálková, J, Tozzi, I, Indrák, K

“…Authors describe the case of a patient suffering from Thrombotic Thrombocytopenic Purpura--Hemolytic-Uremic syndromee. Any cause of the disease was not found,…”
Get more information

Endogenous erythropoietin in patients on regular dialysis therapy by Zadrazil, J, Bachleda, P, Zahálková, J

“…In a group of 66 patients with chronic renal failure having regular dialyzation treatment the serum concentration of endogenous erythropoietin (EPO),…”
Get more information

Dual-photon bone densitometry in dialyzed patients by Jaros, A, Budíková, M, Bartek, J, Zadrazil, J, Konecný, K, Krejcí, K, Vrublovský, P, Zahálková, J, Kosatíková, Z

“…In non-invasive diagnosis of renal osteodystrophy the levels of bone minerals and the extent of bone turnover are evaluated. The contents of bone minerals are…”
Get more information

Mineral and bone disease - CKD 5D by Hecking, M., Kainz, A., Bielesz, B., Plischke, M., Beilhack, G., Hoerl, W. H., Sunder-Plassmann, G., Bieglmayer, C., Benchetrit, S., Green, J., Bernheim, J., Golan, E., Oyake, N., Suzuki, K., Itoh, S., Tanabe, K., Fujimori, A., Okada, S., Yamamoto, K., Sakai, M., Kamiura, N., Solenne, P., Guebre-Egziabher, F., Bacchetta, J., Drai, J., Richard, M., Chapurlat, R., Fouque, D., Nowak, Z., Grzegorz, K., Maria, K., Zofia, W., Zamboch, K., Zahalkova, J., Kosatikova, Z., Skypalova, P., Skarda, J., Cunha, J., Boim, M., Ferreira, V., Naves, M., Kikuchi, H., Shimada, H., Takimoto, Y., Karasawa, R., Shimotori, M., Ikarashi, K., Saito, N., Miyazaki, S., Sakai, S., Suzuki, M., Ogata, H., Takeshima, A., Yamamoto, M., Asakura, K., Kato, T., Shishido, K., Koiwa, F., Mizobuchi, M., Kinugasa, E., Akizawa, T., Londrino, F., Corbani, V., Ardini, M., Falqui, V., Zattera, T., Rombola', G., Takeshige, Y., Matsuzaka, K., Ciceri, P., Volpi, E., Brenna, I., Elli, F., Borghi, E., Brancaccio, D., Cozzolino, M., Farrand, K., Copley, J. B., Heise, J., Fridman, M., Keith, M., Silverberg, A., Wilson, R., Poole, L., Jean, G., Bresson, E., Chazot, C., Maduell, F., Arias, M., Sentis, A., Rodriguez, N., Jimenez, S., Alemany, B., Perez, N., Vera, M., Fontsere, N., Carrera, M., Cases, A., Sonikian, M., Miha, T.

Get full text

Erythropoietin and erythropoiesis after kidney transplantation by Zadrazil, J, Bachleda, P, Grosmanová, T, Zahálková, J, Fingerová, H, Petrová, P, Novotný, D

“…In a group of 15 patients after the first transplantation of a cadaverous kidney the authors monitored for the period of one month the serum erythropoietin…”
Get more information

Acute kidney injury - Human studies

Get full text

Cardiovascular complications in CKD 5D (2)

Get full text

Personal experience with the determination of serum beta-2-microglobulin in patients after kidney transplantation by Zadrazil, J, Zahálková, J, Fischerová, E, Fischer, J, Tomsü, M, Bachleda, P, Grossmannová, T

Get more information

Optimal therapy with erythropoietin (EPO) in patients with renal anemia on hemodialysis therapy by Merta, M, Sobotová, D, Zahálková, J, Bitterová, Z, Jirka, T, Knetl, P, Kopenec, J, Suchanová, J, Vlasák, J

“…Treatment of anaemia of renal origin by recombinant erythropoietin (EPO) is well established and is considered to be an integral part of therapy in patients…”
Get more information

Iron metabolism in patients in kidney failure dialysis treatment by Zadrazil, J, Bachleda, P, Papajík, T, Scudla, V, Zahálková, J, Budíková, M, Novotný, D

Get more information